Myopia at Age 6
What to Expect and What to Do

Short answer: Myopia at age 6 is early-onset — and it carries the highest risk of reaching high myopia by adulthood. A 6-year-old has 12+ years of active eye growth ahead. The IMI 2025 and most clinical guidelines recommend starting myopia management at diagnosis for children this young, not waiting for faster progression.

Current growth phase at age 6: Fastest growth phase — 0.25–0.40mm/year of axial elongation is typical at this age

Clinical picture: what this age means for myopia

A child with myopia at age 6 starting at −1.00D, progressing at 0.50D/year, would reach −7.00D by age 18 without intervention. With 60% effective myopia management, that final prescription becomes approximately −3.40D — a clinically meaningful difference in lifetime structural risk. The Tideman 2018 normative data show this age group in the steepest part of the axial growth curve.

What parents should do now

Treatment options at age 6

Treatment options at age 6: Stellest® spectacle lenses (no minimum age), low-dose atropine 0.01–0.025% (can be used from age 3–4 under supervision). MiSight® is FDA-approved from age 8. Orthokeratology from approximately age 7–8.

See your child's projected prescription at age 18

Enter current age, axial length, and a prior measurement. Get projected adult prescription with and without treatment — in under 60 seconds.

Project myopia progression →
Free · No login · Under 30 seconds

How age at onset predicts lifetime risk

Age myopia startsYears of fast growth remainingHigh myopia risk (without treatment)
Age 6~12 yearsVery high (est. 60–80%)
Age 7~11 yearsVery high (est. 55–75%)
Age 8~10 yearsHigh (est. 45–65%)
Age 9~9 yearsHigh (est. 35–55%)
Age 10~8 yearsModerate–High (est. 25–45%)
Age 12~6 yearsModerate (est. 15–30%)
Age 14~4 yearsLower (est. 10–20%)
Age 16~2 yearsLow (est. 5–12%)

High myopia defined as ≥−6.00D. Risk estimates based on Tideman 2018 longitudinal data; individual outcomes vary substantially. Your row is highlighted.

Sources: Tideman JWL et al. Acta Ophthalmologica. 2018;96(3):301–309 (normative AL curves, age at onset) · Sanz Diez P et al. Ophthalmic Physiol Opt. 2019 (meta-analysis, onset age) · IMI 2025 Digest — Tahhan N et al. · Donovan L et al. Ophthalmic Physiol Opt. 2012;32(3):240–247 (stabilisation data) · Chamberlain P et al. Optom Vis Sci. 2019 (MiSight RCT, age 8+) · Bao J et al. JAMA Ophthalmol. 2022 (Stellest RCT)

This page is for educational purposes and does not constitute medical advice. Diopter-to-axial-length conversions are approximations (±2–3D individual variation). MyopiaTracker is a decision-support tool — not a diagnostic device. Consult a qualified optometrist or ophthalmologist for personalised advice.